Amphetamine Stimulant Prodrug denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies Amphetamine Stimulant Prodrugs on Medical-Necessity Grounds

Cigna's medical-necessity reviews for amphetamine-class prodrugs focus on whether the clinical record clearly supports the diagnosis, establishes that the patient's severity warrants pharmacotherapy, and demonstrates that prior treatments were tried and found inadequate. Because stimulant prodrugs carry controlled-substance status, Cigna reviewers apply close scrutiny to documentation gaps. The most common reason for denial is not that the medication is inappropriate — it is that the submitted record does not explicitly connect the patient's history to each criterion in Cigna's coverage policy.

## Why This Denial Is Appealable

Medical-necessity denials are adverse benefit determinations under ERISA §503 (employer-sponsored plans) and ACA §2719 (marketplace and fully-insured plans). Both frameworks guarantee internal appeal and, if upheld, independent external review by an accredited IRO. The IRO applies clinical evidence standards independently of Cigna's internal policy. External review must typically be requested within approximately four months of the denial notice; expedited review is available when delay poses a risk to health or function. Mental health parity law also applies: Cigna may not apply medical-necessity standards to mental health conditions that are more restrictive than those applied to comparable medical/surgical benefits.

## The Concrete Appeal Process

1. Request the specific criteria used. Cigna must provide the clinical coverage policy on which it relied. Obtain it before drafting the appeal. 2. File the internal appeal with a documentation packet that addresses every criterion in the policy. 3. Cite mental health parity if the denial reflects a more restrictive standard than Cigna applies to comparable medical/surgical benefits. 4. External review: File promptly if the internal appeal is denied, given the IRO's independent clinical standard.

## Documentation to Gather

• Diagnosis confirmation: Chart notes, standardized rating-scale results, or evaluation reports that clearly establish the diagnosis using DSM or ICD criteria recognized in Cigna's policy.
• Severity and functional-impairment evidence: Documentation showing that the condition causes significant impairment in occupational, academic, or daily functioning — not merely symptoms in isolation.
• Prior-treatment history with dates and outcomes: Every prior stimulant and non-stimulant treatment, with specific start/stop dates and documented reasons for discontinuation.
• Prescriber medical-necessity letter: A detailed letter from the treating clinician citing chart-specific facts — not generic claims — for each policy criterion.
• Applicable clinical guideline reference: A citation to the relevant professional society's guideline supporting this treatment approach for the patient's diagnosis.

## Criteria-Mapping Strategy

Obtain Cigna's coverage policy and the FDA label. Build a two-column table: left column contains each policy requirement verbatim; right column provides the specific chart date, note, or test result that satisfies it. If any criterion cannot be addressed, work with the prescriber to supplement the chart before submitting. An unanswered criterion is an invitation to uphold the denial.